From: Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
Strongly agree | Somewhat agree | Neither agree or disagree | Somewhat disagree | Strongly disagree | |
---|---|---|---|---|---|
Benefits | |||||
- Labeling the problem is helpful for patients and family members | 53 (52) | 33 (32) | 6 (6) | 4 (4) | 6 (6) |
- A diagnosis is useful so the patient can be more involved in planning for the future | 45 (44) | 38 (37) | 10 (10) | 6 (6) | 3 (3) |
- A diagnosis can be useful in motivating the patient to engage in risk reduction activities | 43 (42) | 40 (39) | 10 (10) | 5 (5) | 4 (4) |
- A diagnosis helps the family with insurance planning | 28 (27) | 35 (34) | 27 (26) | 6 (6) | 6 (6) |
- A diagnosis helps the family with financial planning | 30 (29) | 47 (46) | 16 (16) | 4 (4) | 5 (5) |
- A diagnosis can be useful for including patients in clinical trials | 71 (70) | 23 (23) | 5 (5) | 3 (3) | 0 |
- Certain medications can be useful for treating some patients | 26 (25) | 39 (38) | 13 (13) | 10 (10) | 14 (14) |
- A diagnosis is useful for the physician to plan the follow-up | 58 (57) | 29 (28) | 7 (7) | 5 (5) | 3 (3) |
Drawbacks and limitations | |||||
- Diagnosing causes unnecessary worry for patients and family members | 4 (4) | 14 (14) | 14 (14) | 36 (35) | 34 (33) |
- There is no approved treatment so it does not make sense to diagnose | 13 (13) | 3 (3) | 12 (12) | 23 (23) | 51 (50) |
- It is too difficult to diagnose accurately or reliably | 4 (4) | 21 (21) | 7 (7) | 30 (30) | 40 (39) |
- A diagnosis has no added value over the diagnosis of MCI | 8 (8) | 9 (9) | 14 (14) | 21 (21) | 50 (49) |